Investigating photoexcitation-induced mitochondrial damage by chemotherapeutic corroles using multimode optical imaging by Hwang, Jae Youn et al.
Investigating photoexcitation-induced
mitochondrial damage by
chemotherapeutic corroles using
multimode optical imaging
Jae Youn Hwang
David J. Lubow
Jessica D. Sims
Harry B. Gray
Atif Mahammed
Zeev Gross
Lali K. Medina-Kauwe
Daniel L. Farkas
Downloaded from SPIE Digital Library on 06 Apr 2012 to 131.215.220.186. Terms of Use:  http://spiedl.org/terms
Investigating photoexcitation-induced mitochondrial
damage by chemotherapeutic corroles using
multimode optical imaging
Jae Youn Hwang,a,b David J. Lubow,b Jessica D. Sims,b Harry B. Gray,c Atif Mahammed,d Zeev Gross,d
Lali K. Medina-Kauwe,b,e and Daniel L. Farkasa,b,f,g
aMinimally Invasive Surgical Technologies Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard D6061, Los Angeles, California 90048
bDepartment of Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Boulevard D3059, Los Angeles, California 90048
cBeckman Institute, California Institute of Technology, Pasadena, California 91125
dTechnion-Israel Institute of Technology, Schulish Faculty of Chemistry, Haifa 32000, Israel
eUniversity of California Los Angeles Geffen School of Medicine, Department of Medicine, Los Angeles, California 90048
fUniversity of Southern California, Department of Biomedical Engineering, , Los Angeles, California 90089
gSpectral Molecular Imaging, Inc., Beverly Hills, California 90211
Abstract. We recently reported that a targeted, brightly fluorescent gallium corrole (HerGa) is highly effective for
breast tumor detection and treatment. Unlike structurally similar porphryins, HerGa exhibits tumor-targeted toxicity
without the need for photoexcitation. We have now examined whether photoexcitation further modulates HerGa
toxicity, using multimode optical imaging of live cells, including two-photon excited fluorescence, differential inter-
ference contrast (DIC), spectral, and lifetime imaging. Using two-photon excited fluorescence imaging, we
observed that light at specific wavelengths augments the HerGa-mediated mitochondrial membrane potential
disruption of breast cancer cells in situ. In addition, DIC, spectral, and fluorescence lifetime imaging enabled
us to both validate cell damage by HerGa photoexcitation and investigate HerGa internalization, thus allowing
optimization of light dose and timing. Our demonstration of HerGa phototoxicity opens the way for development
of new methods of cancer intervention using tumor-targeted corroles. © 2012 Society of Photo-Optical Instrumentation Engineers
(SPIE). [DOI: 10.1117/1.JBO.17.1.015003]
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1 Introduction
Nanotherapy is one of the newest and most promising
approaches for cancer treatment. Currently, significant efforts
are focused on development of novel tumor-targeted drug
molecules, capable of simultaneous diagnosis and treatment
by incorporating active molecules, targeting ligands, and ima-
ging agents. We have recently developed a novel tumor-targeted
drug molecule, which is a single self-assembled complex
between a targeted cell penetration protein (HerPBK10) and
a sulfonated gallium(III) corrole (S2Ga), for breast cancer treat-
ment and detection.1–3 This targeted complex (called HerGa)
results from spontaneous, noncovalent assembly of S2Ga and
HerPBK10 and remains stably intact in serum after assembly.1
S2Ga, in which gallium(III) is chelated by the amphipolar cor-
role whose macrocycle is decorated by two sulphonic acid head
groups, has structural similarity to porphyrins. It not only emits
very intense red fluorescence but also is cytotoxic when allowed
to penetrate through a cell membrane.1,2 HerPBK10, used as a
carrier protein for the complex, contains moieties for DNA
transport and targeted delivery to human epidermal growth fac-
tor receptor 2-positive (HER2þ) cancer cells. It binds DNA
through a polylysine appendage while the EGF-like domain
of the heregulin-alpha isoform is used as the targeting ligand.1
Thus, HerPBK10 specifically targets HER2þ tumor cells, par-
ticularly MDA-MB-435 cells, in a receptor-specific manner and
mediates the entry of targeting molecules in the HER2þ cancer
cells.4 Hence, when S2Ga is assembled with our HerPBK10,
S2Ga can be targeted to and internalized by HER2þ tumor
cells, resulting in tumor-targeted toxicity.2 Importantly, since
S2Ga alone, which is negative charged, is less able to breach
a cell membrane without the membrane-penetrating HerPBK10
protein, HerGa is specifically toxic to target cells at 1 μM con-
centration whereas S2Ga is less toxic to target cells at the same
concentration. Moreover, tumor targeting by HerGa can be read-
ily visualized optically, owing to intense corrole fluorescence.
Hence, HerGa can be used for both tumor detection and
intervention.1,5
Our previous mechanistic study for HerGa6 showed that
HerGa itself damages mitochondria of MDA-MB-435 cancer
cells through induction of reactive oxygen species (ROS). In
particular, HerGa disrupts mitochondrial membrane potentials
in cells, indicating increased mitochondrial membrane perme-
ability. In this study we have also observed, for the first
time, that light at specific wavelengths promotes this disruption
of mitochondrial membrane potential in HerGa-treated cells.
Thus, we here tested whether such photoexcitation further
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modulates HerGa toxicity, using multimode optical imaging of
live cells.
In the present study, we have used multimode optical micro-
scopy7 to characterize a newly discovered property of HerGa:
augmentation of its inherent cytotoxicity by photoexcitation.
The effect of HerGa on mitochondrial membrane potential of
HER2þ MDA-MB-435 cells in situ was examined quantita-
tively before and after light irradiation at specific wavelengths
by measuring mitochondrial accumulation of a fluorescent
cationic probe, Tetramethyl rhodamine methyl ester (TMRM),
which exhibits no inhibitory effect on mitochondrial respiration
when used at low concentrations,8 using confocal and two-
photon excited fluorescence, DIC, and spectral imaging.9,10 In
addition, photoinduced cytotoxicity of HerGa at different light
wavelengths was investigated using standard epi-fluorescence
imaging. We also tested whether red light enhances toxicity,
suggesting that application in vivo is possible. Finally, we
examined HerGa uptake using fluorescence lifetime imaging
in order to determine the optimal time window for light dose
delivery onto treated tumor cells. The complementary imaging
modes used here can reduce measurement errors when imple-
mented together, thus closing potential blind spots that cannot
ordinarily be detected using a single imaging mode.11 The
photoexcitation-enhanced toxicity by HerGa, in combination
with its tumor-targeting and cell-penetration capacity, may
enable further reduction of drug dosage and thus of possible
side effects, thereby increasing therapeutic efficacy and
safety.12,13
2 Materials and Methods
2.1 Materials
MDA-MB-435 cancer cells were obtained from the National
Cancer Institute and maintained at Dulbecco’s modified Eagle’s
Medium (DMEM), supplemented with 10% fetal bovine serum
and penicillin/streptomycin at 37 °C, 5%CO2. HerPBK10 pro-
tein was expressed in Escherichia coli as a histidine-tagged
fusion protein and purified by metal chelate affinity chromato-
graphy as described.14 HerGa was assembled by combining
S2Ga with HerPBK10 at a molar ratio of 30∶1 and purified
as previously described.2 TMRM was purchased from Invitro-
gen. Figure 1 shows the spectral features of absorption (left
panel) and emission (right panel) for HerGa [Fig. 1(a)] and
TMRM [Fig. 1(b)], respectively.
2.2 Mitochondrial Membrane Potential Measurement
Using TMRM
TMRM was used as a potentiometric cationic dye to measure
mitochondrial membrane potential changes, which indicate
mitochondrial membrane permeability,6 in MDA-MB-435
cells treated with indicated reagents. Its distribution across
the mitochondrial membrane is governed primarily by the
Nernst equation: Vm ¼ −ðRT∕ZFÞ lnðcm∕ccÞ,9,15 where Vm is
the mitochondrial membrane electrical potential, Z is the charge
of the permeable ion, F is Faraday’s constant, R is the ideal gas
constant, T is the absolute temperature, and cm and cc the
0
200
400
600
800
1000
1200
1400
1600
550 580 610 640 670 700 730
Fl
uo
re
sc
en
ce
Wavelength (nm)
0
500
1000
1500
2000
2500
3000
3500
500 550 600 650 700 750
Fl
uo
re
sc
en
ce
Wavelength (nm)
0
0.005
0.01
0.015
0.02
0.025
0.03
0.035
0.04
0.045
360 410 460 510 560 610 660 710
A
bs
or
ba
nc
e 
(O
.D
.)
Wavelength (nm)
TMRM
HerGa
0
0.005
0.01
0.015
0.02
360 410 460 510 560 610 660 710
A
bs
or
ba
nc
e 
(O
.D
.)
Wavelength (nm)
Ex: 425nm
Ex: 530nm
(a)
(b)
Fig. 1 Absorption (left) and emission spectra (right) of (a) HerGa and (b) TMRM.
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mitochondrial and cytoplasm probe concentrations. Hence,
accumulation of TMRM in intact mitochondria is reflected
by an increase in their intracellular fluorescence intensity
whereas diffusion into the cytoplasm reduces this. In general,
for precise measurement of mitochondrial membrane potentials,
equilibrium of TMRM accumulation in mitochondria is needed,
and thus we here performed all the experiments after TMRM
accumulation into mitochondria was equilibrated (equilibrium
time: ∼1 h).
2.3 Multimode Optical Microscope for Live Cells
We combined the capabilities of a Leica TCS SP5 two-photon
imaging system and a Nikon TE 2000 microscope for multi-
mode optical imaging, which includes epi-fluorescence, DIC,
confocal, spectral, and fluorescence lifetime imaging modes,
as shown in Fig. 2. For the two-photon excited fluorescence
imaging, tunable femto-second (fs) pulsed laser light (100 fs)
(Mai-Tai Ti-Sapphire laser, Spectra-Physics) is delivered to
the Leica two-photon imaging system, and then the delivered
light passes through an objective (20×, NA: 1.0, Leica) for
excitation of samples. For spectral imaging, spectral selection
is realized by an acousto-optic tunable filter (AOTF), and the
analysis was performed using the spectral classification program
we developed as previously described.16 In addition, for DIC
imaging, DIC optics incorporated in the Leica system were
utilized, with the images recorded by a CCD camera (Photo-
metrics, Coolsnap HQ2). For fluorescence lifetime imaging,
424 nm fs pulsed laser light, which is generated from the second
harmonic of 848 nm fs pulsed laser light (Spectra Physics,
MaiTai) in a Beta Barium Borate (BBO) crystal, is delivered
to cells through an objective in the Nikon TE 2000 microscope
after passage through several mirrors, a diffuser, and a dichroic
mirror. Fluorescence emission is recorded by a CCD connected
to a time-gated intensifier (TGI) (LaVision, Picostar HR).
2.4 Light Dosimetry for Inducing Phototoxity
of HerGa
For light dosimetry, we utilized a mercury lamp incorporated in
the microscopes. Light from the mercury lamp was filtered by
excitation band-pass filters in filter-cubes and then delivered to
cells through the objective utilized for imaging. The energy
density for the light dosimetry was determined by the following
equation: ED ¼ P × t∕A (unit: J∕cm2), where ED is energy
density, P is light power, t is irradiation time, and A is area
receiving light. Here the light power coming from the objective
was measured using an optical power meter (ThorLabs). The
area receiving light was determined by the field of view of
the objective.
2.5 Multimode Optical Imaging of HerGa-Treated
Cells
In order to investigate the effect of light on HerGa-mediated
cytotoxicity, mitochondrial membrane potential/morphology
changes, which indicate cellular health status, of MDA-MB-
435 cells before and after light irradiation (450 to 490 nm,
energy density: 17.1 J∕cm2) were monitored using multimode
optical imaging, including two-photon excited confocal fluores-
cence, DIC, and spectral imaging.17 MDA-MB-435 cells were
plated at 104 cells per Delta T (Bioptechs) chamber and incu-
bated at 37 °C for 36 h before adding TMRM at 20 nM into the
chamber. The cells were exposed to HerGa for three hours
after mitochondrial accumulation of TMRM equilibrated in
treated cells, and two-photon excited fluorescence imaging of
TMRM and DIC imaging were performed in order to measure
mitochondrial membrane potential and morphology changes of
the cells before and after light irradiation, sequentially. Here the
light irradiation of HerGa-treated cells was performed in the pre-
sence of intracellular TMRM to measure mitochondrial mem-
brane potentials of live-cells, and fs pulsed light at 830 nm,
which can excite TMRM very efficiently while barely exciting
HerGa, was utilized for two-photon excitation of TMRM. The
emission from TMRM within the spectral range 550 to 590 nm,
in which the wavelength selection for fluorescence detection
was achieved by AOTF, was collected by an objective. For
the quantitative analyses we acquired images (a 20× objective,
with an additional 7× magnification on the image side) at 30
different focal points within the 12 to 18 μm depth of the speci-
men (depending on cell thickness); then, the z-stack maximum
intensity projection of images were constructed using an analy-
sis program incorporated in the Leica system. In addition, in
30 min after the light irradiation, we acquired the TMRM two-
photon excited images again and performed spectral imaging
and analysis for the discrimination between HerGa and TMRM
inside cells in order to validate the mitochondrial membrane
potential disruption and particularly to assess its reversibility
through examination of HerGa and TMRM localization in the
cells. In particular, we utilized fs pulsed light at 780 nm for two-
photon excitation of HerGa rather than using the fs pulsed light
Fig. 2 Experimental setup for multimode optical imaging: fs pulsed laser
light is delivered into the Leica and Nikon microscope for the excitation
of specimens. For the fluorescence lifetime imaging, the fs pulsed laser
light (424 nm) is frequency-doubled through a BBO crystal. The fre-
quency-doubled pulsed laser light is delivered to samples in a delta
T chamber through several mirrors, a diffuser, a dichroic mirror, and
an objective. Fluorescence detection is realized by TGI and CCD. For
epi-fluorescence imaging, the filtered light from an Hg lamp is used to
excite the samples. The fluorescence from the samples is recorded in
CCD through an emission filter. For two-photon excited fluorescence
imaging, fs pulsed light is directly delivered into the sample through
a scan head, an iris, and an objective; then, the fluorescence is detected
by a photomultiplier tube (PMT) through a shortpass filter, an iris, and
AOTF. The CCD is used for DIC imaging.
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at 830 nm used for excitation of TMRM since the light at
830 nm barely excites HerGa. The emitted light within the
590 to 650 nm range was selected by AOTF for HerGa fluor-
escence detection. However, the fs pulsed light at 780 nm can
still excite TMRM considerably. Thus, the spectral imaging and
analysis was performed to discriminate between HerGa and
TMRM. For the spectral imaging and analysis, 14 images
were acquired within the spectral range of 550 to 680 nm
with step size of 10 nm and followed by analysis using the
spectral classification program we developed as previously
described.14
2.6 Wavelength-Dependence of HerGa
Photo-Reactivity
To assess wavelength-dependence of HerGa photo-reactivity,
we monitored mitochondrial membrane potential changes of the
cells pretreated with HerGa, S2Ga, and PBS for several light
doses (∼3.8 J∕cm2, ∼7.6 J∕cm2, ∼11.4 J∕cm2, ∼15.2 J∕cm2,
∼19 J∕cm2, and ∼22.8 J∕cm2) at different wavelengths (425,
488, 530, and 640 nm), which were selected based on the
absorption spectrum of HerGa. The wavelength selection for
light dosimetry was performed using bandpass filters, through
which the selected light was delivered to samples through a
40× objective incorporated in the Nikon microscope. TMRM
fluorescence images were recorded using the same objective
and a Cy3 filter cube (ex: 545  15 nm, em: 610  40 nm)
to examine mitochondrial membrane potentials of the cells.
In addition, for quantitative analysis, we calculated the fluores-
cence intensity ratios between mitochondria and cytoplasm
sites, which represent the relative mitochondrial membrane
potential value.8,9,18 For the calculation of the ratio, we measured
average fluorescence intensity at 10 different mitochondrial
regions and one mitochondria-free region for cytoplasm,
which was selected around the nucleus, within the cells at
three different fields of view (see Fig. 3).
2.7 Mitochondrial Damages of HerGa-treated Cells
by Red Light
In addition, in order to examine whether red light (590 to
630 nm) also enhances HerGa-mediated mitochondrial damage,
the pretreated cells with 1 μM HerGa and PBS received deep-
blue light (414 to 434 nm, ∼7.6 J∕cm2) and red light (590 to
630 nm, ∼7.6 J∕cm2) at only confined areas through a
20× objective respectively before TMRM addition and then
1 ml of 20 nM TMRM was added to the cells after they
were washed with PBS. TMRM fluorescence and bright-field
images of the cells were recorded using the system with a
10× objective at two hours after the TMRM addition. The
Fig. 3 Light wavelength-dependent disruption of mitochondrial membrane potential in cells treated with HerGa or controls: TMRM fluorescence
images of cells treated with HerGa (1 μM), S2Ga (1 μM), or PBS were obtained after light irradiation at different wavelengths (425, 488, 535, and
640 nm) and with different energies per area (3.8 J∕cm2, 7.6 J∕cm2, 11.4 J∕cm2, 15.2 J∕cm2, 19 J∕cm2, and 22.8 J∕cm2) using epi-fluorescence ima-
ging (objective: 40×, excitation: 535 nm and emission: 580 nm). Graphs depict the ratio of average fluorescence intensities for mitochondria:cytoplasm
of selected cells (N ¼ ∼15 cells per a field of view). Arrows indicate the cytoplasmic and mitochondrial regions, respectively.
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images of TMRM fluorescence were overlaid with bright-field
images for topological comparison. In addition, for quantitative
analysis, mean intensities of TMRM fluorescence of the areas
receiving the light were calculated using Image J.
2.8 Fluorescence Lifetime Imaging of HerGa
Fluorescence lifetime imaging of HerGa was performed by
exciting HerGa with 424 nm fs pulsed laser light in order to
examine whether HerGa fluorescence lifetime could be used
as a live-cell indicator to signal the optimal timing at which
photoexcitation should be applied. The fluorescence lifetime
images of HerGa were acquired at different time points
(3, 10, 20, 40, 60, and 70 min) after the addition of 25 μM
HerGa to cells growing in a Delta T chamber to monitor inter-
nalization. A total of 28 images were acquired (0 ∼ 5200 ps;
time step: 200 ps; gate width: 600 ps, Ex: 424 nm, Em:
620 nm × 60 nm, light pulse width: 100 fs) and analyzed using
the single-exponential decay fitting method, and then the
(pseudocolor) fluorescence lifetime images were constructed.
In addition, we evaluated the fitting significance by comparing
the single and double-exponential fittings of the data obtained at
3 and 20 min, using MATLAB 7.8.
2.9 Examination of Light-Induced Cytotoxicity of
HerGa During Internalization into
MDA-MB-435 Cells
In addition to the fluorescence lifetime imaging of HerGa during
uptake, light-induced cytotoxicity changes of HerGa were
examined during internalization into MDA-MB-435 cells.
The cells were plated at 104 cells per Delta T chamber and incu-
bated at 37 °C for 36 h before adding TMRM at 20 nM into the
chambers respectively. After mitochondrial accumulation of
TMRM was equilibrated, TMRM and DIC images at different
focal planes (thickness: ∼18 μm, step: 1 μm) were acquired;
then, 1 μM HerGa (final concentration) was added into the
cells, and the cells in each chamber received light at 424 nm
(3.8 J∕cm2) at different time points (no treatment, 5, 30,
60 min) after HerGa addition respectively. After the light irra-
diation, TMRM and DIC images at the focal planes were
acquired again and then the z-stack maximum intensity projec-
tion images were constructed. For quantitative analysis, we also
calculated the average fluorescence intensity ratio in between
mitochondria and cytoplasm sites in the images obtained before
and after light irradiation, as described previously, and then the
average ratios were compared, after normalization by the aver-
age value obtained before light irradiation.
3 Results
3.1 Light Specifically Increases HerGa-Mediated
Mitochondrial Membrane Potential Disruption
To assess the effect of light on HerGa-mediated cytotoxicity,
mitochondrial membrane potential/morphology changes (indi-
cating cellular health status) of MDA-MB-435 cells before
and after light irradiation were monitored using multimode
optical imaging, including two-photon excited confocal fluores-
cence, DIC, and spectral imaging.17 Two-photon imaging of
live cells shows that HerGa treatment (1 μM) without light
irradiation reduces TMRM accumulation in mitochondria in
comparison to S2Ga-treated (1 μM) [Fig. 4(c), left panel] and
control (PBS—treated) cells [Fig. 4(d), left panel]. Thus,
TMRM fluorescence in HerGa-treated cells [Fig. 4(a), left
panel] is relatively less than the fluorescence in S2Ga- and
PBS-treated cells without light irradiation. However, this reduc-
tion in the HerGa-treated cells is enhanced further by light irra-
diation [Fig. 4(a), middle panel], and is accompanied by a
rounded morphology [Fig. 4(b), right panel] consistent with
detaching cells that is not observed in the cells treated without
light [Fig. 4(b), left panel]. Importantly, light alone, or in com-
bination with S2Ga and PBS, does not produce this significant
effect [Figs. 4(c) and 4(d)] compared to HerGa.
In addition, we further examined the mitochondrial mem-
brane potential reversibility and the localization of HerGa and
TMRM after the light irradiation. Particularly, the TMRM image
[Fig. 4(a), right panel] acquired at 30 min after the light irra-
diation shows that TMRM does not redistribute across the
mitochondrial membrane reversibly, thus indicating the nonre-
versibility of the mitochondrial changes. Additionally, to vali-
date that the fluorescence acquired from this imaging reflects
that emitted by TMRM rather than by HerGa, as well as to
examine localization of TMRM and HerGa in the cells after
the light irradiation, spectral imaging and analysis were
performed to separate HerGa from spectrally overlapping
TMRM fluorescence signals. The spectral classification images
[Fig. 4(e), right panel] show that while HerGa is indeed accu-
mulated inside cells that have undergone mitochondrial disrup-
tion, TMRM from mitochondria is diffused into the cytoplasm,
as well as extracellularly, consistent with mitochondrial mem-
brane potential collapse and in contrast to control (PBS-treated)
cells. Taken together, these results show that two-photon/DIC/
spectral imaging allows us to monitor and measure the mito-
chondrial membrane potential and morphologic changes of the
HerGa-treated cells −∕þ light. Thus, we can conclude that the
mitochondrial membrane potentials of HerGa-treated cells are
significantly disrupted by light irradiation and that this effect
is not reversible after the light irradiation.
3.2 HerGa-Mediated Disruption of Mitochondrial
Membrane Potential is Dependent on
Photoactivating Light Wavelength
We next examined whether HerGa-mediated cytotoxicity is
dependent on light wavelength by measuring the disruption
of mitochondrial membrane potential at selected excitation
wavelengths of 425, 488, 535, and 640 nm, chosen based on
the absorbance peaks of HerGa. Figure 3 shows that the mito-
chondrial membrane potential of HerGa-treated cells dramati-
cally decreases after 3.8 J∕cm2 of light irradiation at 425 nm
compared to S2Ga and PBS-treated cells. In particular, light irra-
diation does not induce any detectable mitochondrial membrane
potential disruption in PBS-treated cells. The mitochondrial
fluorescence decrease of all treated cells is also shown in the
535 nm light irradiation, thus indicating that the change is
mainly caused by photobleaching of TMRM due to the light
irradiation since 535 nm wavelength of the light significantly
overlaps the excitation wavelengths for TMRM. Finally,
640 nm moderately decreases the mitochondrial membrane
potential of HerGa-treated cells. Altogether, these results
show that light at 424 nm wavelength produces the most
Hwang et al.: Investigating photoexcitation-induced mitochondrial damage by chemotherapeutic : : :
Journal of Biomedical Optics 015003-5 January 2012 • Vol. 17(1)
Downloaded from SPIE Digital Library on 06 Apr 2012 to 131.215.220.186. Terms of Use:  http://spiedl.org/terms
effective toxic effect in HerGa-treated cells, and the toxic effect
is dependent on the absorption spectra of HerGa.
3.3 Long Wavelength Light Can Promote Mitochon-
drial Damage of HerGa-Treated Cells
Figures 3 and 4 show that deep blue light promotes mitochon-
drial damage of HerGa-treated cells most effectively. However,
this approach may not be suitable for in vivo applications since
the penetration depth of the blue light through tissues is very
limited (to a few millimeters at best,19 and typically much less).
Longer wavelength light, on the other hand, would allow for
excitation of HerGa in deep tissue. Fortunately, the gallium-
metallated corrole used here exhibits a secondary absorption
peak around 620 nm.20 Thus, we tested whether red light (590
to 630 nm) can also augment the mitochondrial damage of
HerGa-treated cells. For a comparison, we applied deep blue
light (414 to 434 nm) and red light (590 to 630 nm) on confined
areas of 1 μM HerGa-pretreated cells through a 20× objective,
respectively, and then added TMRM to the cells for the mea-
surement of mitochondrial membrane potential. While the
mitochondrial membrane potential of the cells only receiving
each light at respective wavelengths is disrupted, the cells out-
side of this field (i.e., not receiving the light) retained the mito-
chondrial membrane potential, as shown in Figs. 5(a) and 5(b).
In contrast, the control cells (mock-treated) receiving the light at
590 to 630 nm did not exhibit any significant collapse of mito-
chondrial membrane potential [Fig. 5(c)]. In addition, as shown
in the quantitative analysis Fig. 5(d)), while the mean intensity
of TMRM fluorescence of the HerGa-treated cells receiving the
blue light dose not differ significantly compared to the mean
fluorescence intensity of the cells receiving the red light, it is
much lower than that of the control (PBS) cells receiving the red
light. Thus, these results indicate that red light (590 to 630 nm),
able to penetrate deeper into tissue due to its significantly lower
scattering, can also promote mitochondrial damage of HerGa-
treated cells and suggests that it may be possible to introduce
light-augmented cytotoxicity of HerGa in vivo.
3.4 Fluorescence Lifetime Changes of HerGa During
Internalization into MDA-MB-435 Cells
Our previous studies have shown that internalization of HerGa is
required for cancer cell damage.1 Specifically, we have shown
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Fig. 4 Mitochondrial membrane potential/morphologic changes of cells receiving HerGa treatment before and after light irradiation and spectral
imaging to distinguish HerGa from TMRM: The TMRM fluorescence images of treated cells were acquired before and after light irradiation using
two-photon excited confocal fluorescence imaging. Meanwhile, the DIC images were acquired before and after light irradiation using a CCD camera
coupled with the two-photon imaging system. After the light irradiation, HerGa could be discriminated from TMRM by collecting the two-photon
excited fluorescence images within the spectral range of 550 to 680 nmwith a step size of 10 nm. (a) TMRM fluorescence images of HerGa-treated cells
before (left) and after the light irradiation (middle and right at 30min). (b) DIC images before and after light irradiation. (c) TMRM fluorescence images of
S2Ga treated (left) and (d) control cells (PBS) (right) −∕þ light (450 to 490 nm, 17 J∕cm2). (e) HerGa fluorescence image (left) and spectral classification
image (right, red: HerGa, green: TMRM).
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that HerPBK10-mediated delivery yields accumulation in endo-
cytic vesicles by ∼15 min after uptake, followed by sufficient
cytosolic distribution of HerPBK10 by ∼45 min.1 Hence, we
examined here whether HerGa fluorescence lifetime could
be used as a live-cell indicator to signal the optimal timing at
which photoexcitation should be applied. Figure 6(a) shows
the fluorescence lifetime changes of HerGa during uptake.
Although the average fluorescence lifetime of HerGa in the
cells is approximately 861 ps at 3 min, this average lifetime
of HerGa dramatically decreases to approximately 541 ps at
20 min and to approximately 533 ps at 40 min, respectively.
These time points correlate with cell membrane binding and
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Fig. 5 Mitochondrial disruption of HerGa-treated cells by red light. TMRM fluorescence images were acquired at two hours after the addition of TMRM
to cells treated with 1 μM HerGa and PBS. Cells within the confined area only (delineated by a dotted line) received either deep blue light (414 to
434 nm) or red light (590 to 630 nm), where indicated. (a) Overlaid TMRM fluorescence and transmission image of HerGa-treated cells receiving deep
blue light. (b) Overlaid TMRM fluorescence and transmission image of HerGa-treated cells receiving red light. (c) Overlaid TMRM fluorescence and
transmission image of PBS-treated cells receiving red light. (d) Mean fluorescence intensities of the area received light. The bar graph represents the
mean fluorescence intensity.
Fig. 6 Fluorescence lifetime changes of HerGa during uptake in MDA-MB-435 cells: (a) fluorescence lifetime (inset, upper panels) and intensity (inset,
lower panels) images of treated cells acquired at the indicated time points (3, 10, 20, 40, 60, and 70 min) of HerGa internalization. The plot shows the
changes of average fluorescence lifetime of HerGa at the indicated time points. (b) Gated images (left) and single- and double-exponential fittings (right)
obtained at 3 and 20 min after HerGa addition.
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cytosolic uptake, respectively, as indicated by the fluorescence
intensity images showing HerGa cellular localization during
internalization [Fig. 6(a) inset, lower row].1 Consistent with pre-
vious observations,1,2 HerGa remains excluded from the nucleus
after cytosolic entry. Figure 6(b) shows the gated images (left)
and fluorescence decay curve fittings at the regions selected by
the circles (right), which are obtained at 3 and 20 min respec-
tively after HerGa addition to the cells. Here the fluorescence
decay curves clearly show that fluorescence of HerGa obtained
at 20 min decays faster than the fluorescence of HerGa at 3 min.
In addition, the decay curve fitting significance was evaluated by
comparing the single and double-exponential fits [Fig. 6(b),
right]. While the single-exponential fitting provides a HerGa
fluorescence lifetime of ∼936 ps at 3 min around the selected
region, the double-exponential fitting provides fluorescence
lifetimes of ∼1131 ps and ∼260 ps respectively. In contrast,
while the single-exponential fitting provides a HerGa fluores-
cence lifetime of ∼591 ps at 20 min around the selected regions,
the double-exponential fitting provides a fluorescence lifetime
of 831 ps and ∼260 ps respectively. Altogether, these results
show that HerGa uptake is fully achieved within ∼40 min
after HerGa addition to cells, thus allowing us to identify the
optimal timing for inducing photoexcitation-based damage.
3.5 Monitoring of Light-Augmented Cytotoxicity of
HerGa During Uptake
Fluorescence lifetime imaging of HerGa during uptake
allows us to identify the optimal timing for inducing
photoexcitation-based damage. We furthermore investigated
the light-induced cytotoxicity changes of HerGa during uptake
by monitoring mitochondrial membrane potential changes of the
cells after light irradiation (424 nm, 3.8 J∕cm2). Figure 7(a)
shows the TMRM fluorescence images obtained before and
after light irradiation of the cells at the indicated time points
(no treatment, 5, 30, 60 min) after HerGa addition. In the
cells without HerGa treatment, the light irradiation does not
induce any significant disruption of mitochondrial membrane
potential of the cells [Fig. 7(a), first column]. In contrast, the
cells receiving the light (424 nm, 3.8 J∕cm2) at 5 min after
HerGa addition exhibit significant disruptions of mitochondrial
membrane potential [Fig. 7(a), second column], and furthermore
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Fig. 7 Mitochondrial disruption of HerGa-treated cells by light irradiation at the indicated time points after HerGa addition: (a) TMRM images obtained
before and after light irradiation at 5, 30, and 60 min after HerGa addition and without HerGa treatment and overlaid TMRM and DIC image after light
irradiation. (b) Quantitative analysis for mitochondrial membrane potential disruption. The bar graph represents the average mitochondrial membrane
potential. The error bars indicate standard deviations.
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in the cells receiving the light at 30 and 60 min after the HerGa
addition, more significant disruptions of mitochondrial mem-
brane potential [Fig. 7(a), third and fourth columns] were
observed than in the cells receiving light at 5 min. As shown
in the quantitative analysis [Fig. 7(b)], which exhibits the aver-
age mitochondrial membrane potentials, while the average
mitochondrial membrane potential of the cells decreases to
approximately 50% by the light irradiation at 5 min after
HerGa addition, the average mitochondrial membrane potentials
decrease down to approximately 30% and 15% by the light
irradiation at 30 and 60 min after the HerGa addition, respec-
tively [Fig. 7(b)]. Altogether, these results show that the photo-
augmented cytotoxicity of HerGa can be realized at about 5 min
after HerGa addition to the cells, but the light-induced cytotoxi-
city of HerGa becomes enhanced as the HerGa treatment time
increases.
4 Discussion and Conclusions
The present studies indicate that whereas HerGa at 1 μM
concentration disrupts mitochondria without photoexcitation,
additional light application (at specific wavelengths) augments
mitochondrial membrane potential disruption even further, thus
enhancing HerGa’s inherent cytotoxicity. Although light at
424 nm (which correlates with the peak absorption wavelength
of HerGa) is most effective at augmenting this cytotoxicity, light
at 535 nm also significantly lowered the TMRM fluorescence
that reports on the mitochondrial membrane potential. However,
the wavelength itself also overlaps with the absorption wave-
length of TMRM [Fig. 1], and the apparent disruption observed
at 535 nm is likely to be caused mainly by reactive oxygen
species generated by TMRM although it is somewhat affected
by HerGa photo-reactivity.21 In addition, light at 424 nm can
induce moderate mitochondrial damage in S2Ga-treated cells,
but considerably less compared to HerGa-treated cells [Fig. 3].
Whereas S2Ga alone can be endocytosed with serum albumin, it
cannot effectively penetrate the plasma membrane and enter the
cytosol without a membrane-penetrating agent. As cytosolic
entry appears to be a requirement for S2Ga toxicity, S2Ga
alone is fairly nontoxic to cancer cells unless used at excessive
pharmacological concentrations (>30 μM).1,2 In addition, light
at 450 to 490 nm, which still excites HerGa but is not perfectly
matched with the absorption peaks of HerGa, can also disrupt
mitochondrial membrane potential of HerGa-treated cells
with higher energy density (17.1 J∕cm2) of light irradiation
[Fig. 4(a)] than at 424 nm [. 3]. These results indicate that
all light within wavelengths that can be absorbed by HerGa
augments mitochondrial membrane potential disruption of
HerGa-treated cells, with different light doses.
Our previous study showed that HerGa molecules are
diffusely localized in the cytoplasm. In this study, both HerGa
fluorescence [. 4(e), left] and spectral classification imaging
[Fig. 4(e), right] show that HerGa is broadly distributed in
the cytoplasm before and after light irradiation. Whereas fluor-
escence imaging shows that HerGa overlaps with mitochondria
(marked by TMRM fluorescence) [Fig. 4(a), left], the localiza-
tion of HerGa is not exclusive to mitochondria and does not
exhibit the punctuate fluorescence that would be suggestive
of mitochondrial accumulation. Therefore, although it is unli-
kely that HerGa specifically enters the mitochondrion, it is prob-
able that HerGa is in near enough proximity to elicit the results
shown in this study. Further studies will help us elucidate the
direct interactions facilitating HerGa-mediated reactive oxygen
species formation. In Fig. 4(e), the region selected for TMRMþ
background should contain TMRM since TMRM accumulation
in mitochondria and cytoplasm is governed by the Nernst equa-
tion; TMRM diffuses into the cytoplasm from mitochondria
after mitochondrial disruption and subsequently diffuses out
of cells. Meanwhile, HerGa, which is not internalized into
the cells, still remains in the region. Therefore, the spectral
signature labeled with TMRMþ background [Fig. 4(e), middle]
exhibits two peaks around 570 and 620 nm. While the first peak
is likely to result from TMRM, the second peak is likely to result
from HerGa. However, there are some mismatches in between
the chosen spectral signature and the pure spectral signature of
TMRM, which may result from a low fluorescence signal
level. Therefore, it seems reasonable to have this labeled
TMRMþ background.
For more versatile (and translational) in vivo application of
the light-augmented toxicity of HerGa, the usage of light at
longer wavelengths than the deep blue is required. Figure 5
shows that red light (590 to 630 nm) also enhances HerGa-
mediated mitochondrial damage [Fig. 5(b)], suggesting that
photoexcitation of HerGa may be implemented in vivo. Whereas
the optimal wavelength for breast cancer phototreatment is
reported to be 730 nm,22 the wavelength used here still lies
partially within the red/NIR window (626 to 1316 nm)
for breast tissue. Additionally, HerGa can be excited by fs
pulsed light at 780 nm through the two-photon absorption
process as shown in Fig. 4(b).23 This result indicates that the
two-photon excitation may also be applicable to the photoexci-
tation of HerGa in vivo. Thus, it is possible that photoexcitation
can enhance the inherent toxicity of HerGa and, when combined
with tumor targeting in vivo,1 may present an effective alterna-
tive breast cancer treatment, especially for resistant disease
states such as metastasis.24 However, although the red light
(590 ∼ 630 nm) can also effectively yield mitochondrial disrup-
tion of HerGa-treated cells, the 640 nm (red) light wavelength as
shown in Fig. 3, which is not perfectly matched with the second
peak absorption wavelength (∼620 nm), does not induce a sharp
decrease of Mito/Cyto ratio compared to the 425 nm light wave-
length. These results indicate that the wavelength selection is a
key factor to induce more effective mitochondrial damage in
HerGa-treated cells by light irradiation. Interestingly, in
Fig. 5(a), the area showing mitochondrial membrane potential
disruption is not somewhat matched with the irradiation area.
The mismatch is likely due to the light scattered from the
focal spot. As shown in Fig. 3, the light-induced cytotoxicity
of HerGa is dependent on the absorbance of HerGa. The absor-
bance spectra of HerGa have peaks at approximately 424 and
620 nm while the absorbance at 424 nm is over twice that at
620 nm. Thus, the deep blue light (414 to 434 nm) is more effec-
tive than the red light (590 to 630 nm) at the same energy density
for augmenting the cytotoxicity of HerGa. Thus, the scattered
deep blue light seemed to be capable of disrupting mitochon-
drial membrane potentials of cells adjacent to the area mainly
receiving the light but not the red light at the light dose.
Photoactivation of TMRM itself induces singlet oxygen21
and thus prolonged photoactivation of TMRM-loaded cells
resulted in stronger NAD(P)H oxidation and the rapid onset of
mitochondrial permeability transition. Thus, in the measurement
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of mitochondrial membrane potential using TMRM, care-
ful determination of light dose for excitation of TMRM is
needed. In this study, photoactivation of TMRM at the light
dose utilized for imaging did not induce any significant mito-
chondrial membrane potential disruption (fluorescence intensity
changes of TMRM after acquisition of 187 images: 630 to 612).
In addition, the TMRM images, shown in Figs. 4 and 5,
indicate that the light application augments mitochondrial
membrane potential disruption although they were obtained
through two different procedures: 1. TMRM → HerGa
treatment → irradiation; 2. HerGa treatment → irradiation →
TMRM. Thus, these results suggest that the presence of
TMRM while HerGa irradiation occurs does not have any sig-
nificant effects on the light-augmented cytotoxicity of HerGa
to cells.
Therapeutic efficacy of HerGa requires membrane penetra-
tion of the therapeutic cargo. The membrane-penetrating
segment of HerPBK10, the adenovirus-derived penton base,
plays a critical role for the delivery of genes into cells as
shown in our previous studies,14 and our more recent in vitro
studies show that HerPBK10 enables passage of sulfonated cor-
roles across the plasma membrane.2 Our present studies indicate
that photoexcitation-enhanced mitochondrial disruption can
occur at approximately five minutes after HerGa treatment as
shown in Fig. 7. Moreover, the light irradiation at the longer
time points after HerGa addition induces augmented mitochon-
drial membrane potential disruption of the cells. Concurrent
fluorescence lifetime and intensity imaging indicate that inter-
nalization of HerGa is realized within approximately 40 min,
during which the fluorescence lifetime of HerGa decreases,
consistent with our previous observations.22 Altogether, these
results indicate that the light irradiation at the longer time points
after HerGa treatment provides more enhanced light-induced
cytotoxicity of HerGa.
Since our previous studies indicate that HerPBK10-mediated
cell entry occurs by receptor-mediated endocytosis and endoso-
mal escape,2,11 the fluorescence lifetime changes of HerGa during
uptake may reflect intracellular microenvironmental changes
encountered during its transit. As the microenviroment of the
cytosol of tumor cells is less acidic than outside cells, this
may be indicative of pH changes although this issue remains
to be elucidated. In the fluorescence lifetime imaging of
HerGa (Fig. 6), the fluorescence lifetimes obtained by using a
single-exponential fitting method are shorter than the long-
lived components of the double-exponential decay, possibly
due to the constant short-lived component (260 ps) resolved
by the double-exponential fitting method. Here, the short-lived
component of the double-exponential decay may result from
autofluorescence. In general, the double-exponential fitting
method would provide a better fit than the single-exponential fit-
ting method.25 However, it is important to note that the single
exponential fitting still allows us to monitor the internalization
of HerGa since it offers monitoring of the relative fluorescence
lifetime changes of HerGa during the uptake with the similar
trend to those obtained by the double-exponential fitting method.
In conclusion, although we have previously reported that
targeted corroles can eliminate tumor growth without photo-
activation,1 we now report that photoexcitation augments cor-
role cytotoxicity by enhancing disruption of the mitochondrial
membrane potential. These studies were enabled through
multimode optical imaging, which allowed simultaneous exam-
ination of mitochondrial membrane potentials, cell morphology
changes, discrimination between molecules with similar emis-
sions, and HerGa internalization dynamics, yielding mechanis-
tic and practical conclusions. The combination of the inherent
targeted cytotoxicity of HerGa with its newly discovered photo-
reactivity may facilitate an even greater potency and specificity
for tumor cell destruction, thus yielding a therapeutic with
optimized efficacy and safety.26
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